Business Standard

Vista Pharmaceuticals Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended 31.03.2024. VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Dire...Read More21/05/2024
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 <b>Format of the Annual Disclosure to be made by an entity identified as a Large...Read More30/04/2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A <b>Format of Initial Disclosure to be made by an entity identified as a Large Co...Read More30/04/2024
Compliance Under Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 Compliance Certificate30/04/2024
Compliance As Per Regulation 40 (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended 31.03.2024 PCS Certificate30/04/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under reg 74 (5) of SEBI (DP) Regulations 201821/04/2024
Closure of Trading Window Closure of Trading Window29/03/2024
Intimation Of Appointment Of Company Secretary & Compliance Officer; Company Secretary Appointment disclosure10/02/2024
Outcome Of Board Meeting Under Regulation 30 Read With 33 (3) (C) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Board Meeting Outcome10/02/2024
Board Meeting Intimation for Approval Un Audited Financial Results For The Quarter Ended 31.12.2023 VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Dire...Read More02/02/2024
Outcome Of Circular Resolutions Passed By Board Of Directors Of The Company By Circulation On 29.01.2024 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Circular resolution29/01/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Reg. 74(5) of SEBI (DP) Regulations 201813/01/2024
Announcement under Regulation 30 (LODR)-Allotment Kindly note the allotment of 266667 equity shares pursuant to the conversion of...Read More08/01/2024
Announcement under Regulation 30 (LODR)-Allotment Kindly take note of the allotment of 640000 equity shares pursuant to the conve...Read More28/11/2023
Newspaper Advertisement For The Quarter Ended 30.06.2023 Newspaper advertisement of unaudited financial statements for the quarter ended ...Read More22/08/2023
Announcement under Regulation 30 (LODR)-Allotment Kindly take note of the allotment of 2332625 equity shares on conversion of 233...Read More18/07/2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of SEBI (DP) Regulations 201814/07/2023
Announcement under Regulation 30 (LODR)-Allotment Announcement of Outcome of Board Meeting pursuant to Regulation 30 of the Securi...Read More13/07/2023
Announcement under Regulation 30 (LODR)-Allotment Allotment of 333333 Equity Shares on conversion of 333333 warrants to the other...Read More30/06/2023
Closure of Trading Window Intimation for closure of Trading Window for the Quarter ended 30th June 2023.30/06/2023

Load more